Lupin to focus on development of inhalers with near-zero global warming potential propellants Read more
Dr Reddy’s Laboratories among top 15 biotech and pharma employers in Science Magazine Survey Read more
Lilly’s donanemab could bring new hope to Alzheimer’s patients in Australia following lecanemab rejection: GlobalData Read more
Missing the obvious in technology transfer. Focusing on coating process. | 19th November 2024 Read more
NICE rejects second Alzheimer’s drug but opportunity remains for decision change: GlobalData Read more